RARE (Ultragenyx Pharma) Pangali Forward P/E

Logo grafis ultragenyx.com (RARE)

Ultragenyx Pharmaceutical (RARE) maintains an impeccable reputation in the treatment of rare pathologies, as evidenced by the dynamics of the company's forward P/E, where the 217.30 level serves as a critical benchmark for investment security. The high cost of cryogenic delivery for life-saving drugs complicates logistics and increases expenses. Business efficiency is sustained through flexible outsourcing of early-stage development via a network of external laboratories.

RARE - Pangali forward rega marang bathi ultragenyx.com ing rentang 04.07.2022 - 18.11.2026

Ultragenyx (RARE) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:Ultragenyx Pharmaceutical RARE
Produk mawa merek ultragenyx.com

To minimize investment risks, it is critical to evaluate share value through the lens of expected earnings, which is particularly relevant for Ultragenyx Pharmaceutical (RARE) given its gene therapy strategies and M&A potential. By analyzing the company's forward P/E fluctuations, an investor compares the current price with future earnings to determine the extent to which the market has priced in the success of innovative DNA modifications and partnership synergies.

Karo sapa Ultragenyx Pharmaceutical saingan

Prakiraan rega marang bathi TEM (Tempus AI, Inc)|Qiagen Group (QGEN) - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep ionispharma.com IONS|Kapitalisasi marang proyeksi bathi Repligen Corporation (RGEN)|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (CRISPR Therapeutics Corp)|WGS: Pangali Forward P/E|Beam Therapeutics Corp - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi SRPT|twistbioscience.com (TWST) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E TXG|NTLA (Intellia) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Stoke STOK|BioLife (BLFS) - Rasio prakiraan rega marang bathi|wavelifesciences.com - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake MAZE|SION: Pangali Forward P/E|PRME - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi TSHA|QURE - Pangali forward rega marang bathi|Pangali Forward P/E MGTX|Kapitalisasi marang proyeksi bathi regenxbio.com|Pangali Forward P/E SLDB (Solid Biosciences Inc)|OCGN: Rasio rega marang bathi mangsa ngarep|PACB - Rega marang bathi mangsa ngarep|Benitec (BNTC) - Prakiraan rega marang bathi|DSGN: Pangali Forward P/E|RCKT: Rasio kapitalisasi marang bathi mangsa ngarep|FDMT (4D Molecular Therapeutics, Inc.) - Pangali Forward P/E|lexeotx.com (LXEO) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E KRRO|Prakiraan rega marang bathi Editas Medicine, Inc. EDIT|Rega marang bathi mangsa ngarep silence-therapeutics.com SLN|PRQR: Rasio rega marang bathi mangsa ngarep|CDXS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Metagenomi, Inc. (MGX)|Prakiraan rega marang bathi DTIL|Rasio rega marang bathi mangsa ngarep GBIO (generationbio.com)|Rega marang bathi mangsa ngarep Boundless Bio, Inc (BOLD)|Pangali Forward P/E Exicure Inc. (XCUR)|Imunon, Inc. - Prakiraan rega marang bathi|PHIO: Rasio rega marang bathi mangsa ngarep|MBIO - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake RNAZ|Bionano Genomics, Inc. (BNGO) - Rega marang bathi mangsa ngarep|Applied DNA Sciences, Inc. (APDN) - Pangali Forward P/E|BLUE (bluebirdbio.com) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise Antibodies)|Pangali Forward P/E OMGA|Prakiraan rega marang bathi Singular Genomics Systems OMIC|Pangali Forward P/E RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON)|UBX: Pangali Forward P/E